These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 32200874)

  • 21. CRISPR/Cas: a Nobel Prize award-winning precise genome editing technology for gene therapy and crop improvement.
    Li C; Brant E; Budak H; Zhang B
    J Zhejiang Univ Sci B; 2021 Apr; 22(4):253-284. PubMed ID: 33835761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CRISPR/Cas9-Directed Gene Editing for the Generation of Loss-of-Function Mutants in High-Throughput Zebrafish F
    Shankaran SS; Dahlem TJ; Bisgrove BW; Yost HJ; Tristani-Firouzi M
    Curr Protoc Mol Biol; 2017 Jul; 119():31.9.1-31.9.22. PubMed ID: 28678442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The promise and peril of CRISPR gene drives: Genetic variation and inbreeding may impede the propagation of gene drives based on the CRISPR genome editing technology.
    Zentner GE; Wade MJ
    Bioessays; 2017 Oct; 39(10):. PubMed ID: 28863233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeted Base Editing Systems Are Available for Plants.
    Marzec M; Hensel G
    Trends Plant Sci; 2018 Nov; 23(11):955-957. PubMed ID: 30224156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and application of CRISPR/Cas9 technologies in genomic editing.
    Zhang C; Quan R; Wang J
    Hum Mol Genet; 2018 Aug; 27(R2):R79-R88. PubMed ID: 29659822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CRISPR-Cas9 system: A new-fangled dawn in gene editing.
    Gupta D; Bhattacharjee O; Mandal D; Sen MK; Dey D; Dasgupta A; Kazi TA; Gupta R; Sinharoy S; Acharya K; Chattopadhyay D; Ravichandiran V; Roy S; Ghosh D
    Life Sci; 2019 Sep; 232():116636. PubMed ID: 31295471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CRISPR-Cpf1 assisted genome editing of Corynebacterium glutamicum.
    Jiang Y; Qian F; Yang J; Liu Y; Dong F; Xu C; Sun B; Chen B; Xu X; Li Y; Wang R; Yang S
    Nat Commun; 2017 May; 8():15179. PubMed ID: 28469274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CRISPR/Cas9 System and its Research Progress in Gene Therapy.
    Liu W; Yang C; Liu Y; Jiang G
    Anticancer Agents Med Chem; 2019; 19(16):1912-1919. PubMed ID: 31633477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extending CRISPR-Cas9 Technology from Genome Editing to Transcriptional Engineering in the Genus Clostridium.
    Bruder MR; Pyne ME; Moo-Young M; Chung DA; Chou CP
    Appl Environ Microbiol; 2016 Oct; 82(20):6109-6119. PubMed ID: 27496775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CRISPR Genome Engineering for Human Pluripotent Stem Cell Research.
    Chaterji S; Ahn EH; Kim DH
    Theranostics; 2017; 7(18):4445-4469. PubMed ID: 29158838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current situation of biofuel production and its enhancement by CRISPR/Cas9-mediated genome engineering of microbial cells.
    Javed MR; Noman M; Shahid M; Ahmed T; Khurshid M; Rashid MH; Ismail M; Sadaf M; Khan F
    Microbiol Res; 2019 Feb; 219():1-11. PubMed ID: 30642460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of CRISPR/Cas9 system for targeted DNA modifications and recent improvements in modification efficiency and specificity.
    Shin J; Oh JW
    BMB Rep; 2020 Jul; 53(7):341-348. PubMed ID: 32580834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evolution in crop improvement approaches and future prospects of molecular markers to CRISPR/Cas9 system.
    Dheer P; Rautela I; Sharma V; Dhiman M; Sharma A; Sharma N; Sharma MD
    Gene; 2020 Aug; 753():144795. PubMed ID: 32450202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Challenges of in vitro genome editing with CRISPR/Cas9 and possible solutions: A review.
    Ebrahimi V; Hashemi A
    Gene; 2020 Aug; 753():144813. PubMed ID: 32470504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CRISPR-cas System as a Genome Engineering Platform: Applications in Biomedicine and Biotechnology.
    Hashemi A
    Curr Gene Ther; 2018; 18(2):115-124. PubMed ID: 29473500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid Control of Genome Editing in Human Cells by Chemical-Inducible CRISPR-Cas Systems.
    Liu KI; Ramli MNB; Sutrisnoh NB; Tan MH
    Methods Mol Biol; 2018; 1772():267-288. PubMed ID: 29754234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic screens and functional genomics using CRISPR/Cas9 technology.
    Hartenian E; Doench JG
    FEBS J; 2015 Apr; 282(8):1383-93. PubMed ID: 25728500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Viral Delivery Systems for CRISPR.
    Xu CL; Ruan MZC; Mahajan VB; Tsang SH
    Viruses; 2019 Jan; 11(1):. PubMed ID: 30621179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Smart Programmable CRISPR Technology: A Next Generation Genome Editing Tool for Investigators.
    Chakraborty C; Teoh SL; Das S
    Curr Drug Targets; 2017; 18(14):1653-1663. PubMed ID: 27231109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The rise and future of CRISPR-based approaches for high-throughput genomics.
    Vercauteren S; Fiesack S; Maroc L; Verstraeten N; Dewachter L; Michiels J; Vonesch SC
    FEMS Microbiol Rev; 2024 Sep; 48(5):. PubMed ID: 39085047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.